Zevra Therapeutics Cash Flow Statement (2014-2026) | ZVRA

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Mar2014 Jun2014 Sep2014 Dec2014 Mar2015 Jun2015 Sep2015 Dec2015 Mar2016 Jun2016 Sep2016 Dec2016 Mar2017 Jun2017 Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating Activities
Net Income (Quarter)
6.20M-1.76M-2.68M10.48M-21.97M-5.67M-35.49M-13.22M-2.57M-10.37M-19.89M-16.62M-19.93M-33.23M-35.74M-3.10M74.71M-0.54M12.16M37.89M
Share-based Compensation (Quarter)
0.32M0.62M0.82M0.92M1.51M0.91M0.95M0.94M1.10M1.39M1.47M2.12M2.63M6.14M4.02M3.12M2.46M2.77M4.28M3.10M
Gains from Sales and Divestitures (Quarter)
0.77M
Gains from Investment Securities (Quarter)
0.39M-0.33M-0.09M0.01M-0.03M-0.02M-0.40M0.00M45.72M0.13M0.29M1.11M156.60M-156.60M308.87M
Asset Writedowns and Impairment (Quarter)
3.20M2.00M58.71M-0.02M0.50M
Non-cash Items (Quarter)
0.25M11.82M11.09M17.45M
Cash from Operations (Quarter)
16.60M-2.73M-0.85M-3.55M-4.10M-6.60M-4.46M-4.04M-8.70M-4.63M-16.16M-16.16M-19.11M-18.14M-16.25M-8.22M-3.60M4.71M5.52M6.14M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter)
0.55M1.06M1.21M0.86M0.12M
Amortization of Deferred Charges (Quarter)
-0.14M0.24M0.47M0.78M0.60M0.66M0.69M0.69M0.61M
Depreciation & Amortization (CF) (Quarter)
0.06M0.07M0.06M0.07M0.18M0.40M0.30M0.08M0.08M0.06M0.79M1.56M1.56M1.62M1.65M1.65M1.65M0.39M0.36M0.37M
Change in Working Capital
Change in Receivables (Quarter)
-9.42M-0.27M-0.09M1.79M-0.50M3.35M2.13M-0.48M6.21M-4.11M7.45M-9.07M0.64M-1.16M2.72M2.11M4.86M-1.36M6.37M-6.89M
Change in Inventory (Quarter)
-0.04M-0.24M0.13M-0.05M-0.07M-0.07M-0.02M2.58M0.99M0.58M4.71M0.20M0.38M0.19M0.53M0.18M
Change in Account Payables (Quarter)
-4.39M
Change in Accured Expenses (Quarter)
0.12M-0.19M0.78M-0.49M1.12M0.63M1.87M3.84M-0.89M2.45M5.73M-7.31M-1.30M-1.99M6.99M-7.26M-4.00M-4.73M0.41M-0.53M
Other Working Capital Changes (Quarter)
2.37M-2.73M-0.09M-0.30M2.19M-0.70M-0.30M-0.70M0.49M0.19M-0.12M-0.30M1.16M-0.41M-1.08M-0.19M0.49M-0.84M-0.13M0.42M
Investing Activities
Capital Expenditures (Quarter)
0.02M0.06M0.02M0.02M0.01M0.03M0.03M0.03M0.02M0.17M0.07M0.10M0.21M0.55M-0.03M0.04M
Sales of Property, Plant and Equipment (Quarter)
-0.14M0.04M
Change in Intangibles (Quarter)
43.94M
Acquisitions (Quarter)
14.08M30.40M
Change in Acquisitions & Divestments (Quarter)
0.30M9.50M15.62M14.79M10.01M0.20M18.00M12.50M60.50M87.50M93.97M
Cash from Investing Activities (Quarter)
-0.08M-0.00M-15.44M-3.85M-33.08M0.27M-0.06M-17.55M34.04M-44.46M10.59M14.79M-0.13M-31.35M-5.47M10.54M11.93M-4.58M0.23M79.62M
Financing Activities
Other financing activities (Quarter)
-1.54M0.07M-0.07M
Cash from Financing Activities (Quarter)
39.75M1.94M-2.87M9.09M-0.48M-0.26M-3.75M0.95M26.26M5.00M1.22M15.33M64.77M0.80M1.61M1.38M6.53M2.55M-52.80M
Additional items
Exchange Rate Effect (Quarter)
0.01M0.19M0.07M-0.27M-0.10M0.35M-0.04M0.32M-0.49M0.67M-0.37M0.66M0.06M-0.32M0.23M
Change in Cash (Quarter)
56.27M-0.79M-19.16M-12.13M-23.43M-6.65M-4.66M-25.29M26.02M-22.93M-0.22M-0.20M-3.59M14.78M-20.25M3.56M10.37M6.73M7.97M33.19M
Beginning Cash Balance (Quarter)
Free Cash Flow (Quarter)
16.59M-2.79M-0.86M-3.57M-4.12M-6.63M-4.50M-4.07M-8.73M-4.80M-16.23M-16.16M-19.11M-18.14M-16.25M-8.32M-3.81M4.16M5.55M6.11M
Net Cash Flow (Quarter)
56.27M-0.79M-19.16M-7.40M-28.10M-6.80M-4.78M-25.35M26.28M-22.82M-0.57M-0.15M-3.91M15.27M-20.93M3.93M9.71M6.66M8.29M32.96M